Chemical Name | (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(propionyloxy)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic acid |
Molecular Formula | C27H36F2O6 |
Molecular Weight | 494.57 |
Chemical Name | (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(propionyloxy)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic acid |
Molecular Formula | C27H36F2O6 |
Molecular Weight | 494.57 |
Chirality | (6S,9R,10S,11S,13S,14S,16R,17R) |
Functional Groups | hydroxy, carboxyl, carbonyl, propionyloxy, difluoro |
Chemical Name | (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(propionyloxy)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic acid |
Molecular Formula | C27H37F2O6 |
Molar Mass | 496.58 g/mol |
Physical State | Solid (predicted) |
Appearance | White to off - white powder (predicted) |
Solubility | Insoluble in water (predicted), soluble in organic solvents like ethanol (predicted) |
Logp | 3.5 - 4.5 (predicted) |
Chemical Structure | A complex polycyclic structure with a cyclopenta[a]phenanthrene backbone, containing fluorine, hydroxyl, methyl, carbonyl, propionyloxy and carboxylic acid functional groups |
Chirality | Multiple chiral centers (6S,9R,10S,11S,13S,14S,16R,17R) |
Chemical Formula | C27H36F2O6 |
Molecular Weight | 494.57 |
Iupac Name | (6S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(propionyloxy)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic acid |
What is the chemical structure of (6S, 9R, 10S, 11S, 13S, 14S, 16R, 17R) -6,9 -difluoro-11 -hydroxy-10,13,16 -trimethyl-3 -oxo-17- (propionyloxy) -6,7,8,9,10,11,12,13,14,15,16,17 -dodecyl-3H -cyclopento [a] phenanthrene-17 -carboxylic acid?
(6S, 9R, 10S, 11S, 13S, 14S, 16R, 17R) - 6,9 - dihydro - 11 - methoxy - 10,13,16 - trimethyl - 3 - oxo - 17 - (succinylacyloxy) - 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 - dodecyl - 3H - cyclopentano [a] phenanthrene - 17 - carboxylic acid. The chemical structure of this compound is similar to that of the world described in "Tiangongkai", and it has a unique structure. Among its structures, there are many specific groups and spatial configurations.
Looking at its configuration, (6S, 9R, 10S, 11S, 13S, 14S, 16R, 17R) determines the spatial orientation of its atoms, which is the basis for the structure. "6,9-dihydrogen" indicates that the hydrogenation of carbon-carbon double bonds at positions 6 and 9 is saturated, which seems to make the structure of this region more stable. "11-methoxy", the methoxy group is attached to the 11-position carbon, which seems to add a unique "decoration" to the site, affecting its chemical and physical properties. "10,13,16-trimethyl", the three methyl groups are located at positions 10, 13, and 16, respectively, which have an effect on the spatial resistance and electron cloud distribution of molecules. " 3-Oxo ", the 3-position carbon forms a carbonyl group, which has active chemical properties and can participate in many chemical reactions." 17 - (succinyl oxy) ", the succinyl oxy group is attached to the 17 position, enriching the structure of the molecule and giving it specific reactivity. And" 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 - dodecyl-3H - cyclopentano [a] phenanthrene "describes the main carbon ring structure. This polycyclic structure is the skeleton of the compound and establishes its basic shape." 17-carboxylic acid ", the 17-position carboxyl group, makes the compound acidic and can react with bases. Overall, this chemical structure is delicate and complex, and the interaction of various parts jointly determines the properties and functions of the compound.
(6S, 9R, 10S, 11S, 13S, 14S, 16R, 17R) -6,9 -difluoro-11 -hydroxy-10,13,16 -trimethyl-3 -oxo-17- (propionyloxy) -6,7,8,9,10,11,12,13,14,15,16,17 -dodecyl-3H -cyclopento [a] phenanthrene-17 -carboxylic acid What are the main uses?
(6S, 9R, 10S, 11S, 13S, 14S, 16R, 17R) -6,9-dihydro-11-methoxy-10,13,16-trimethyl-3-oxo-17- (isobutoxy) -6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopentano [a] phenanthrene-17-carboxylic acid The main use is similar to the "Tiangong Kaiwu" in the simple words, when it is said:
This compound is beneficial in the field of medicine. Its unique structure may play a key role in regulating human physiology. For example, in the treatment of certain diseases, after careful investigation and experimentation, it can become a good medicine for symptoms. With its chemical properties, it can participate in the biochemical reactions of the human body and repair the physiological mechanisms of disorders, so as to achieve the purpose of curing diseases and relieving symptoms.
In the field of scientific research, it is also an important research object. Scientists can analyze its structure and characteristics, gain insight into the delicate laws of organic chemistry, explore more novel synthetic paths, lay the foundation for the creation of new compounds, expand the cognitive boundaries of chemistry, and inspire the possibility of more innovation in the future.
And in the process of drug development, it can be used as a lead compound. Using it as a model, researchers can carefully modify and ingeniously modify it to optimize its pharmacological activity, improve its efficacy, reduce side effects, and help develop safer and more efficient innovative drugs, injecting vitality into the progress of the pharmaceutical industry and benefiting all living beings.
What are the pharmacological effects of (6S, 9R, 10S, 11S, 13S, 14S, 16R, 17R) -6,9 -difluoro-11 -hydroxy-10,13,16 -trimethyl-3 -oxo-17- (propionyloxy) -6,7,8,9,10,11,12,13,14,15,16,17 -dodecyl-3H -cyclopento [a] phenanthrene-17 -carboxylic acid?
(6S, 9R, 10S, 11S, 13S, 14S, 16R, 17R) -6,9-dihydro-11-methoxy-10,13,16-trimethyl-3-oxo-17- (glutaryl-oxy) -6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopentano [a] phenanthrene-17-carboxylic acid This drug has the effect of regulating the balance of hormones in the human body. It can act on the human endocrine system and regulate the synthesis and metabolism of steroid hormones. In the physiological process of steroid hormones, it can initiate a series of signal transduction pathways by specifically binding to corresponding receptors, thereby affecting cell proliferation, differentiation and function. For example, in maintaining the normal physiological function of the reproductive system, the drug can regulate the level of sex hormones, which has positive significance for gonadal development, germ cell generation and sexual function maintenance. In addition, it also plays an important role in physiological processes such as human stress response and immune regulation, which can help the body cope with various internal and external environmental changes and maintain the stability of the internal environment.
(6S, 9R, 10S, 11S, 13S, 14S, 16R, 17R) -6,9 -difluoro-11 -hydroxy-10,13,16 -trimethyl-3 -oxo-17- (propionyloxy) -6,7,8,9,10,11,12,13,14,15,16,17 -dodecyl-3H -cyclopento [a] phenanthrene-17 -carboxylic acid What are the precautions in the preparation process?
When processing (6S, 9R, 10S, 11S, 13S, 14S, 16R, 17R) - 6,9 - dihydro - 11 - methoxy - 10,13,16 - trimethyl - 3 - oxo - 17 - (succinyl acyloxy) - 6,7,8,9,10,11,12,13,14,15,16,17 - dodecahydro - 3H - cyclopentan [a] phenanthrene - 17 - carboxylic acid, there are indeed many things to pay attention to.
First, the processing environment is crucial. It needs to be processed in a clean, dry and well ventilated environment. Because of the damp gas, it is easy to cause the drug to mildew and rot, which damages its active ingredients and greatly reduces the efficacy of the drug; and poor ventilation, it may cause the odor of the drug to accumulate and affect the quality. Remember that "Tiangong Kaiwu" mentioned all kinds of craftsmanship, all of which are suitable for the environment, and this processing is no exception.
Second, the heat control must be accurate. If the firepower is too fierce, it is easy to cause the drug to burn, not only losing its original nature, but even producing harmful substances; if the firepower is too weak, it is difficult to achieve the purpose of processing, the transformation of the drug ingredients is not complete, and the efficacy of the medicine is difficult to show. Just like the ancient swords, if the heat is not appropriate, the sword is difficult to make.
Third, the selection and treatment of medicinal materials should not be underestimated. It is necessary to choose medicinal materials of good quality, no impurities, and no moths. Before processing, it is necessary to wash, slice or pulverize according to its characteristics, so that the drug is in full contact with the processing excipients, and the processing effect is uniform.
Fourth, the processing excipients are used properly. If what kind of excipients and the amount of dosage are selected, it will affect the medicinal properties of the drug. Improper material selection may cause changes in the taste of the drug and lose its original effect.
Finally, the recording of the processing process is also key. Detailed records of processing time, temperature, dosage of excipients, etc., are not only convenient for traceability and verification, but also conducive to summarizing experience, improving processing skills, and ensuring stable drug quality. Only by treating all the details carefully when processing this medicine can high-quality medicine be produced and its due effect be exerted.
(6S, 9R, 10S, 11S, 13S, 14S, 16R, 17R) -6,9 -difluoro-11 -hydroxy-10,13,16 -trimethyl-3 -oxo-17- (propionyloxy) -6,7,8,9,10,11,12,13,14,15,16,17 -dodecyl-3H -cyclopento [a] phenanthrene-17 -carboxylic acid What is the market prospect?
(6S, 9R, 10S, 11S, 13S, 14S, 16R, 17R) - 6,9 - dihydro - 11 - methoxy - 10,13,16 - trimethyl - 3 - oxo - 17 - (isobutoxy) - 6,7,8,9,10,11,12,13,14,15,16,17 - dodecahydro - 3H - cyclopentano [a] phenanthrene - 17 - carboxylic acid, this is a more complex organic compound.
The prospect of this compound in the market is like exploring an unknown territory. Although its structure is unique, it seems to contain unlimited potential, but it also faces many variables.
First, in terms of pharmacological properties, if this compound has unique biological activities, it may emerge in the field of medicine. If it can precisely act on specific biological targets and provide a new way for the treatment of diseases, its market prospect will be bright. However, in order to achieve this, long and rigorous research and trials are required to clarify its efficacy, safety and side effects.
Second, in the chemical industry, if it can be used as a key intermediate to participate in the synthesis of other high-value compounds, it can also open up a broad market space. However, it needs to consider the difficulty of its synthesis, the cost and the market demand for downstream products.
Third, market competition is also a factor that cannot be ignored. If there are compounds with similar functions that are preconceived and occupy market share, then this compound needs to have unique advantages, such as higher efficiency, lower cost or better performance, in order to stand out.
In summary, although this compound seems to have hidden market opportunities due to its unique structure, it is necessary to make unremitting efforts in research, development and market expansion to uncover its true face in the market.